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Abstract: Plant-derived polysaccharides have been reported for diverse biological response modification (BRM) and immunotherapeutic
(IT) activities in animals by activating their defense systems to perform better immunogenically against invading pathogens. Keeping
this in view, this study was conducted to assess the BRM and IT activities of barley (Hordeum vulgare L.)-derived arabinoxylans (AXs)
against coccidiosis in broilers. Significantly enhanced (P < 0.05) in vivo and in vitro lymphoproliferative responses to T-cell mitogens
were revealed in broilers administered barley AXs when compared to the control group. Humoral immune response in terms of antibody
titers against sheep erythrocytes was also found higher (P < 0.05) in AX-administered chickens. Furthermore, AX-administered
chickens also showed higher weekly weight gains and improved feed conversion ratios as compared to controls. Results of the challenge
experiment showed that the percentage of protection and daily weight gains were statistically higher (P < 0.05) whereas mean oocysts
per gram of droppings and lesion scores were significantly lower (P < 0.05) in the chickens administered barley AXs as compared to
controls. In conclusion, barley-derived AXs led to better growth performance and elicited humoral and cellular immune responses in
commercial broilers that persisted against coccidial infection in broiler chickens.
Key words: Biological response modification, arabinoxylans, immunotherapy, avian coccidiosis

1. Introduction
Herbs and parts of different plants have been used as
medicinal sources for the treatment of different ailments
since early ages (1). The literature reveals that more than
64% of people globally use botanical drugs for the treatment
of different ailments (2) and on average more than 50%
of synthetic drugs have been isolated from different
plants or herbs (3). In this regard, cereals are one of the
major sources of different drugs or chemical substances
with different pharmacological aspects. Cereals contain
various bioactive compounds, mainly polysaccharides,
phenols, terpenoids, glycosides, and alkaloids (4,5). In
the last few years, a variety of biomolecules, especially
polysaccharides, have been extracted and used by different
researchers to demonstrate the biological mechanisms of
action for their pharmacological activities (6). Among
cereals, barley (Hordeum vulgare L.) is one of the important
cereal grains belonging to the grass family Poaceae (7). It
contains different biological compounds such as vitamin
E, the B-complex, minerals, and phenolic compounds
(8). In Pakistan, it is being cultivated on 75,000 ha and
its annual production is 70,000 t (9). Barley is frequently
* Correspondence: veterinary@bzu.edu.pk

used in human and animal food, for the production of
certain beverages and fermentable products, and in the
malt processing industry (10). Arabinoxylans (AXs),
nonstarch polysaccharides, are important components of
cereal fibers including barley (11). AXs are mainly present
in the bran portion of cereals in varying concentrations
ranging from >4% to <10% (12). AXs are nondigestible
oligosaccharides, which are protected from the digestive
effect of the small intestine in humans with complete
and/or incomplete fermentation in the large intestine
(13). These carbohydrates help to maintain the normal
environment of the colon and possibly contribute to
human health by eliminating the risk of chronic diseases
(13). Many nondigestible oligosaccharides are considered
to be prebiotics that improve the health/efficiency of the
host by stimulating the proliferation and/or activity of one
or a few favorable bacterial species in the colon (14). It
has been established that AXs have immunomodulatory
and protective effects against avian coccidiosis; they also
increased the daily weight gain in broiler chicks (4). AXs
enhanced the immune response and downregulated the
enterotoxigenic Escherichia coli response (15). Barley-
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extracted AXs have strong immunomodulatory effects
against bowel cancer (16) and enhance the phagocytic
activity of macrophages. Furthermore, they also have
positive impacts on leukocyte number and spleen cell
proliferation (17). Other biological activities of AXs include
remarkable increases in thymus growth, spleen index, and
antitussive activity (17,18). Previous studies also revealed
antioxidant, antitumor, and prebiotic properties of AXs
(17,19).
The poultry industry in Pakistan still lacks proper
concern regarding different infectious ailments and
coccidiosis is one of the major concerns. Previously,
studies have been conducted on different formulations of
herbs and plants for a good remedy or therapy to control
this difficult disease. Although different plants have been
studied on the basis of their immunomodulatory effects
against coccidiosis, no such work has been conducted on
barley-derived AX polysaccharides. Keeping in view the
diverse activity of AXs from different sources, this study
was conducted to investigate the biological response
modification (BRM) and immunotherapeutic (IT)
activities of barley-derived AXs against coccidiosis in
chicken.
2. Materials and methods
2.1. Procurement and pretreatment of barley bran
Barley (Hordeum vulgare L.) grains were procured from
a local market in Faisalabad, Pakistan, and processed to
obtain destarched bran following the method of Akhtar
et al. (4). The bran thus obtained was stored at 4 °C until
further use.
2.2. Extraction of AXs
Polysaccharide from the destarched bran was extracted
following the method of Zhou et al. (20) with minor
modifications. Briefly, dried barley bran powder (100 g)
was mixed with 1.5 L of 0.15 N NaOH and 0.5% H2O2
(v/v) for 90 min at 80 °C. The mixture was cooled to room
temperature (26 °C) and centrifuged (314 × g for 30 min).
The supernatant thus collected was neutralized with 0.2
N HCl (pH 4.5) followed by centrifugation (314 × g for
30 min) to concentrate up to one-fourth of the actual
volume under decreased pressure. The concentrate was
precipitated with the help of ethanol (65%), preceded by
centrifugation (314 × g for 30 min at 4 °C). The sediment
was dissolved in water and centrifuged (314 × g for 30 min
at 4 °C). The supernatant was again precipitated by ethanol
(65%) and the same procedure was repeated. The fractions
thus obtained as sediments were used as the alkaline
extract of polysaccharides and freeze-dried until further
use.
2.3. Infective material
Sporulated oocysts of mixed Eimeria species, E. tenella,
E. acervulina, and E. necatrix, maintained in the

56

Immunoparasitology Laboratory of the University of
Agriculture, Faisalabad (UAF), Pakistan, were used for the
challenge experiment in this study. The infective dose was
adjusted to 6.5–7.0 × 104 sporulated oocysts per 5 mL of
phosphate-buffered saline.
2.4. Experimental design
A total of 200 one-day-old broiler chicks (Hubbard strain)
were purchased from a local hatchery and raised in a
coccidia-free environment at the Animal House of the
Faculty of Veterinary Science, UAF. All the chickens were
fed anticoccidial-free feed and water ad libitum. Chickens
of all groups were vaccinated against endemic infection
according to the local vaccination schedule. During the
experimental trial, all procedures were performed in
accordance with the guidelines of the Institutional Animal
Care and Use Committee of UAF.
At 7 days of age, chickens were randomly divided into
four equal groups, A1, A2, A3, and A4 (n = 50 in each group),
and administered barley AXs for 3 consecutive days (i.e. at
7, 8, and 9 days of age) as follows:
Group A1 = Barley AXs @ 100 mg/kg of body weight
(BW)
Group A2 = Barley AXs @ 200 mg/kg of BW
Group A3 = Barley AXs @ 300 mg/kg of BW
Group A4 = Negative control with no treatment
2.5. Evaluation of BRM activities of barley AXs
On day 14 following AX administration, 30 chickens of
each group were used for immunological evaluation and
the remaining 20 birds were used for a therapeutic trial.
Lymphoproliferative response to phytohemagglutinin-P
(PHA-P) and concanavalin-A (Con-A) and antibody
response to sheep red blood cells (SRBCs) were used to
detect the cell-mediated and humoral immune responses,
respectively.
Classic toe-web assay was used to quantify the in vivo
lymphoblastogenic response as described by Corrier (21),
whereas in vitro response was determined according to the
methodology described by Qureshi et al. (22).
Anti-SRBC antibody titers were detected using
a microplate hemagglutination test (23) with minor
modifications (24).
2.6. Weekly weight gains and feed conversion ratios
(FCRs)
Chickens from all groups were weighed individually every
week after the administration of AXs. Feed given to each
group was also recorded on a weekly basis and the data
thus obtained were used to calculate the FCRs using the
following formula:
FCR = Feed consumption (g) / body weight gain (g)
2.7. Immunotherapeutic evaluation
Twenty chickens from each group were infected with 6.5–
7.0 × 104 sporulated oocysts of mixed species of the genus
Eimeria (local isolates E. tenella, E. acervulina, and E.
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necatrix) on day 14 following AX administration. Chickens
of all groups were monitored for body weight gain per day
and oocyst counts using the McMaster counting technique
(25) from day 3 to 12 following the challenge with Eimeria
species. During the challenge experiment, chickens of each
group were also monitored for mortality. Dead chickens
were scored for lesion scoring and surviving chickens
in all groups were also slaughtered and scored (26). The
percentage of protection against lesions was determined
using the following formula:
Percent protection against lesions = Average lesion
score (IUG) – average lesion score (IMG) / average lesion
score (IUG) × 100
Here, IUG = infected untreated group and IMG =
infected medicated group.
Chickens of each group were separately weighed and
slaughtered on day 12 following the challenge. Lymphoid
organs like the bursa of Fabricius, thymus, spleen, and
cecal tonsils were excised and weighed. The data were
presented as percent organ to body weight ratios.
2.8. Statistical analysis
Data thus collected were statistically analyzed through
one-way ANOVA and Duncan’s multiple range tests using
statistical analysis software (27). The difference in mean
values of different groups was considered significant at P
< 0.05.

followed by those recorded at 48 and 72 h after injection.
At 24 h, a significantly higher response (P < 0.05) was
detected in experimental chickens administered barley
AXs at dose rates of 200 and 300 mg/kg of BW when
compared with the control group. At 48 h, irrespective
of the dose, all experimental groups revealed statistically
higher responses (P < 0.05) as compared to the control,
whereas, at 72 h only the chickens administered with AXs
at a dose rate of 300 mg/kg of BW showed statistically
higher responses (P < 0.05) as compared to the control
group (Figure 1a).
3.1.2. In vitro lymphoproliferative response to Con-A
At day 7 after the administration of barley AXs,
lymphoproliferative response to Con-A was significantly
higher (P < 0.05) in group A3 (0.81 ± 0.01), followed by
group A2 (0.72 ± 0.00), A1 (0.41 ± 0.11), and A4 (0.24 ±
0.04), respectively. A similar response was detected on day
14 after the administration of barley AXs (Figure 1b).
3.1.3. Antibody response to SRBCs
At day 7 post primary injection (PPI) of SRBCs, total antiSRBCs titers (geomean titers) were higher in chickens
administered barley AXs in graded doses when compared
with the control group; however, a difference was also
observed among the experimental groups administered
graded doses of barley AXs. A similar response was
detected on day 14 PPI of SRBCs. Moreover, results
showed similar patterns of total anti-SRBC antibody titers
on days 7 and 14 post secondary injection (PSI) of SRBCs
like those on days 7 and 14 PPI of SRBCs. On the whole,
the highest total antibody titers were detected in chickens
of group A2 administered barley AXs at a dose rate of
200 mg/kg BW (Table 1). A similar pattern of results was
recorded for IgM anti-SRBC antibody titers (Table 1).

3. Results
3.1. Evaluation of BRM activity
3.1.1. In vivo lymphoproliferative response to PHA-P
The maximum lymphoproliferative response in terms
of toe-web swelling was recorded at 24 h after injection
of PHA-P both in AX-administered and control groups,
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Figure 1a. In vivo lymphoproliferative response to phytohemagglutinin-P in
experimental and control chickens.
Bars not sharing similar letters in the same time intervals differ significantly (P < 0.05).
A1 = Barley-derived AXs @ 100 mg/kg of BW; A2 = barley-derived AXs @ 200 mg/kg of
BW; A3 = barley-derived AXs @ 300 mg/kg of BW; A4 = control.
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Figure 1b. In vitro lymphoproliferative response to concanavalin-A in experimental
and control chickens.
Bars not sharing similar letters in the same time intervals differ significantly (P < 0.05).
A1 = Barley-derived AXs @ 100 mg/kg of BW; A2 = barley-derived AXs @ 200 mg/kg of
BW; A3 = barley-derived AXs @ 300 mg/kg of BW; A4 = control.
Table 1. Antibody titers to sheep red blood cells in experimental and control chickens.
Total anti-SRBC antibody titers
Group

Day 7 PPI

Day 14 PPI

Day 7 PSI

Day 14 PSI

A1

36.76

27.86

48.50

32.00

A2

55.72

42.22

64.00

48.50

A3

42.22

36.76

55.72

42.22

A4

21.11

18.38

27.86

12.13

A1

24.63

9.48

20.65

11.74

A2

34.6

17.97

27.24

11.74

A3

23.85

15.64

23.72

10.22

A4

11.92

4.45

9.48

2.94

A1

12.13

18.38

27.86

27.85

A2

12.11

24.25

36.76

36.76

A3

18.38

21.11

32.00

32.00

A4

9.19

13.93

18.38

9.18

Immunoglobulin-M

Immunoglobulin-G

PPI = Post primary injection; PSI= post secondary injection.
A1 = Barley-derived AXs @ 100 mg/kg of BW; A2 = barley-derived AXs @ 200 mg/kg of BW; A3 = barley-derived AXs
@ 300 mg/kg of BW; A4 = control.

On day 7 PPI of SRBCs, the IgG anti-SRBCs antibody
titer was highest in group A3 administered barley AXs
(300 mg/kg BW), followed by those of groups A2 and A1,
respectively. On days 14 PPI, 7 PSI, and 14 PSI of SRBCs,
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the patterns of IgG titers in the experimental and control
groups were similar to those obtained for total anti-SRBC
antibodies titers on the corresponding days (Table 1).
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3.2. Effect on weekly body weight gains
The effect of barley AXs on live body weight gains
was recorded on a weekly basis from week 1 to week 5
following the administration of barley AXs. The results
showed significantly higher (P < 0.05) weight gains in
chickens administered barley AXs as compared to those
of the control group, whereas among the AX-administered
groups, significantly higher (P < 0.05) response was
detected in chickens of group A2 when compared with
those of groups A1 and A3 (Table 2).
3.3. Feed conversion ratios
FCR was measured on a weekly basis in all groups from
week 1 to week 5 following the administration of AXs.
All AX-administered groups showed improved FCRs as
compared to controls. On the whole, the most improved
weekly FCRs were detected in chickens of group A1 (2.07),
followed by those of group A2 (2.08), group A3 (2.11), and
the control group (2.20).

3.4. Challenge experiment
3.4.1. Oocyst count
Results revealed significantly lower (P < 0.05) oocyst counts
in experimental groups administered AXs as compared
to controls. On the other hand, among the experimental
groups, chickens of group A2 (200 mg/kg BW) showed the
lowest counts, followed by those of groups A1 (100 mg/kg
BW) and A3 (300 mg/kg BW), respectively; the difference
among experimental groups was statistically significant (P
< 0.05) (Table 3).
3.4.2. Percent protection
The highest protection (65%) was recorded in chickens
of group A3 (300 mg/kg BW), followed by those of
group A2 (60%), group A1 (55%), and the control group
(35%). Chi-square analysis revealed a significantly higher
protection rate (P < 0.05) in all AX-administered groups
compared to the control, whereas the difference among
AX-administered groups was statistically similar. In

Table 2. Weekly weight gains in chickens from week 1 to week 5 after administration of arabinoxylans in
experimental and control chickens.
Week

Groups
A1

A2

A3

A4

1

395 ± 26.6b

410 ± 4.56a

405 ± 5.92a

394 ± 4.56b

2

596 ± 16.7b

589 ± 6.52b

610 ± 5.15a

575 ± 11.2c

3

980 ± 8.22

1005 ± 8.08

964 ± 8.72

910 ± 8.54d

4

1450 ± 9.7c

1530 ± 9.82a

1480 ± 7.42b

1370 ± 2.4d

5

1885 ± 5.7b

1930 ± 3.24a

1830 ± 9.11c

1650 ± 12.3d

b

a

c

Means sharing similar letters in a row are statistically nonsignificant (P > 0.05).
A1 = Barley-derived AXs @ 100 mg/kg of BW; A2 = barley-derived AXs @ 200 mg/kg of BW; A3 = barley-derived
AXs @ 300 mg/kg of BW; A4 = control.

Table 3. Oocysts per gram of droppings after challenge in experimental and control chickens.
Days after challenge

Groups
A1

A2

A3

A4

4

17,338 ± 45.18

1261 ± 15.53

1410 ± 15

35,643 ± 174.69a

5

21,831 ± 39.95b

2972 ± 25.42d

3699 ± 11c

51,459 ± 178.84a

7

191,755 ± 205.9b

7100 ± 112.58d

11,994 ± 216c

205,203 ± 719.03a

9

221,606 ± 171.85b

24,491 ± 232.77d

41,559 ± 317.08c

316,010 ± 280.15a

11

312,691 ± 184.37b

22,167 ± 159.9d

18,281 ± 157.8c

352,602 ± 530.45a

12

305,752 ± 97.2

13,315.67 ± 343.22

b

b

d

d

c

14,104 ± 176.01

c

345,407 ± 238.7a

Means sharing similar letters in a row are statistically nonsignificant (P > 0.05).
A1 = Barley-derived AXs @ 100 mg/kg of BW; A2 = barley-derived AXs @ 200 mg/kg of BW; A3 = barley-derived AXs
@ 300 mg/kg of BW; A4 = control.
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general, it was observed that chickens maintained on AXs
were relatively active with better feed and water intake as
compared to the control group, in which chickens were
lethargic with ruffled feathers and with less water and feed
intake. Among postmortem findings, severe hemorrhagic
lesions were found in the intestines of the birds of the
control group while birds of AX-administered groups
showed less severe lesions.
3.4.3. Lesion scoring
Both dead and surviving (sacrificed) chickens in all
groups were scored for lesions on the intestines and ceca.
The chickens were observed for lesion scoring on a scale
of 0 to 4 on the basis of severity of lesions. Lower cecal
lesion scores were recorded in groups administered with
AXs when compared with the control group. The score
of severe cecal lesions (3–4) was maximum (75%) in the
control group, whereas in experimental groups the score
for severe lesions ranged from 30% to 60%. The lowest
score for severe cecal lesions was seen in group A3 (AXs
at a dose rate of 300 mg/kg BW). Similar to the cecal
lesions, the score of severe intestinal lesions was also
found maximum (80%) in the controls. Minimum severe
intestinal lesions (3–4) were recorded in group A3 (25%),
followed by groups A2 (35%) and A1 (55%), respectively.
Percentage protections against intestinal and cecal lesions
are shown in Figure 2.
3.4.4. Daily weight gains after challenge
The effect of barley AXs on daily weight gain of chickens
was recorded from day 3 to day 12 following challenge
with mixed species of Eimeria and results are expressed as
grams (±SE) (Table 4). The chickens of AX-administered
groups showed significantly higher (P < 0.05) weight gains
when compared to controls. Among the AX-administered
groups, those administered with AXs at a dose rate of 200
mg/kg of body weight showed the highest daily weight

% Protection against lesions

60

A1

A2

A3

gains followed by groups A2 and A3, respectively, and the
difference was statistically significant (P < 0.05).
4. Discussion
Barley is one of the major cereal crops being cultivated
throughout the world (9). It is mainly used for malting,
beverages, and human and animal foods (7). It is mainly
composed of starch (49.4%–66.2%), dietary fiber (13.6%–
27.5%), and crude protein (9.3%–21.9%) (28). Dietary
fiber contains variable amounts of polysaccharides like
AXs and β-glucans. The AXs, nonstarch polysaccharides,
are the primary components of the cell wall of different
cereals including oat, barley, rice, rye, and wheat (29,30)
and in barley bran their concentration is 4%–11%
(12,28). Pharmacological activities of cereal-derived
polysaccharides, especially AXs, decreased the glucose
level in diabetes patients and increased fecal output (31).
AXs also have prebiotic effects on the gastrointestinal tract
by stimulating intestinal bacteria, which have beneficial
effects on health (32,33). Immunomodulatory activities
of AXs, either by enhancing the activity of natural killer
cells (34) or reducing inflammation and pain, were also
reported previously (18,35). Results of the present study
revealed higher cellular immune responses in chickens
administered barley-derived AXs as compared to those
of the control group. The higher level of cellular immune
responses in chickens administered a graded dose of
AXs might be attributed to the enhanced effects on
the phagocytic activity of macrophages that may cause
increase in the thickness of the toe-web due to T-cell
mitogens (36,37). Toe-web swelling in response to PHA-P
in chickens due to enhanced delayed-type hypersensitivity
suggested that the magnitude of immune response might
be dependent on the function and number of lymphocytes
(38,39). Therefore, it can be speculated that an increase in

A4

50
40
30
20
10
0

Ceca

Lesion sites

Intestine

Figure 2. Percent protection against cecal and intestinal lesions following challenge in
experimental and control groups.
A1 = Barley-derived AXs @ 100 mg/kg of BW; A2 = barley-derived AXs @ 200 mg/kg of
BW; A3 = barley-derived AXs @ 300 mg/kg of BW; A4 = control.
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Table 4. Daily weight gains from day 3 to day 12 after challenge in experimental and control chickens.

Days after challenge

Groups
A2

A1

A3

A4

2

33 ± 1.0

35.3 ± 1.53

31.67 ± 1.53

26 ± 1.00c

3

32.67 ± 1.53b

38.67 ± 1.53a

33.00 ± 2.00b

26.67 ± 2.08c

4

34.33 ± 1.53b

35.33 ± 1.16a

31.67 ± 1.53b

24.33 ± 1.16c

5

28.33 ± 1.53c

32.67 ± 1.53a

30.67 ± 2.08b

22.33 ± 1.53c

6

25.33 ± 1.53c

32.67 ± 1.53a

29.33 ± 2.08b

21.33 ± 1.53d

7

25.67 ± 1.53b

30.33 ± 1.53a

28.67 ± 1.53b

22.3 ± 1.16d

8

26.67 ± 2.52b

31.67 ± 2.08a

27.67 ± 1.53b

21.33 ± 1.53c

9

23.67 ± 2.52b

28.33 ± 0.58a

29.33 ± 1.5a

22.00 ± 1.00b

10

25.00 ± 3.0a

30.67 ± 2.08a

30.00 ± 1.00a

23.00 ± 1.00b

11

31.33 ± 2.52a

32.00 ± 2.00a

30.33 ± 1.53a

25.33 ± 0.58b

12

34.67 ± 2.08a

35.67 ± 0.58a

31.33 ± 0.58c

27.33 ± 2.08c

ab

a

b

Means sharing similar letters in a row are statistically nonsignificant (P > 0.05).
A1 = Barley-derived AXs @ 100 mg/kg of BW; A2 = barley-derived AXs @ 200 mg/kg of BW; A3 = barley-derived AXs
@ 300 mg/kg of BW; A4 = control.

the number and activity of lymphocytes in the lymphoid
tissue may be responsible for the development of the
improved immune response (40,41).
The birds administered barley AXs showed higher in
vitro lymphoblastogenic response when compared with
the control group. This higher response might be due to
the fact that T-cells containing mitogen receptors undergo
cell division upon coming into contact with Con-A (22).
Furthermore, it could also be speculated that Con-A
stimulated the peripheral blood leukocytes, which produced
IL-1 by monocytes in the peripheral blood leukocyte
fraction, which stimulated the propagation of lymphocytes
(42). The higher humoral immune responses in barley AXadministered chickens might be due to stimulatory effects
of polysaccharides on the classical complement pathway in
serum by their interaction with antibodies (43,44). Results
of the present study are consistent with previous findings
of similar studies that oral administration of sugars
resulted in higher antibody titers to SRBCs in chickens
artificially inoculated with Eimeria, elevated antibody
response to SRBCs in immunocompromised chickens,
increased serum antibody responses against SRBCs and
Brucella abortus, and increased number of plasma cells in
PBLs, enteric leukocytes, and splenocytes (4,36,37,39,45).
Results of this study showed higher body weight gains
and improved FCRs in chickens administered graded
doses of barley AXs as compared to those of the control
group. The improved body weight gains and FCRs in AX-

administered birds might be correlated with the ability
of AXs to reduce the environmental stress and infectious
insults by immunostimulation (37).
In the coccidiosis disease model, weight gain and
oocyst count are two important parameters to detect the
severity of the disease (4,39,46). In this study, increased
weight gain and lower oocyst counts were recorded in
AX-administered chickens, which indicated the resistance
against Eimeria infection, although the direct relationship
was not measured in the current study. Immune-enhancing
effects of various native foods and herbal preparations on
hosts against microbes and tumors have been reported
to have a direct correlation with their ability to induce
lymphocyte proliferation (47,48). In the case of coccidiosis,
some medicinal foods and probiotic extracts have been
reported as protective agents against various bacterial
and parasitic infections by accelerating the cellular and
humoral immunity against Eimeria (39,45,49). In this
challenge experiment, a higher protection rate was detected
in AX-administered groups as compared to controls. It
has been reported that polysaccharides potentiate the
complement system and antibodies to stop or minimize
parasitic infestation, especially Eimeria, in chickens
(43,44). Cereal-derived AXs have also shown some effects
of protection by interacting with local immune responses
(4,39), which might be responsible for activation of
specific immunity against coccidiosis (45), thus ultimately
resulting in lower oocyst counts. Furthermore, chickens
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of the AX-administered groups were relatively active with
higher weight gains as compared to the control group.
Lower weight gains in control groups might be attributed
to homeostasis imbalance in the gastrointestinal tract
(50) leading to less feed intake, slower metabolism, and
eventually lower weight gains (51–53). Furthermore,
lower body weights might also be due to inflammation and
maximum energy utilization against coccidial invasion
and hence poor weight gains (39,54). On the other hand,
higher body weight gains in AX-administered chickens
might be correlated with the activity of AXs to stimulate
the monocytes, natural killer cells, and neutrophils that
release cytokines and enhance the leukocyte activity, thus
efficiently improving the mechanism of host recovery
(31). Previous studies also revealed the activity of
polysaccharides to activate macrophages against different

microorganisms and thus enhance protection against their
pathogenic effects (55).
In conclusion, barley-derived AXs showed
immunostimulatory and growth-promoting effects in
broiler chickens and subsequently provided protection
against Eimeria infection. Further studies are required
for the elucidation of the exact mechanism(s) of action
involved in such immunostimulatory activities. In the
future, it would definitely help to investigate the possibility
of the use of barley-derived AXs as effective nutraceuticals
in the poultry industry.
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